Header image

Session 3C: The new rules of biotechnology: Competing in the next generation of innovation

Tracks
Track 3
Wednesday, October 21, 2026
3:05 PM - 3:50 PM
Discovery & Advanced Therapeutics Breakout Room

Details

Biotechnology is entering a new era. Artificial intelligence, platform technologies and digital biology are transforming not only how medicines are discovered, but how biotechnology companies are built, how partnerships are formed and where competitive advantage is created. As traditional models give way to increasingly integrated, technology-enabled approaches, the next generation of biotechnology companies will look fundamentally different. Bringing together leaders in AI-enabled discovery, computational biology, platform innovation and digital R&D, this leadership discussion explores the forces reshaping biotechnology and the opportunities these changes present for companies, researchers and innovation ecosystems around the world.


Speaker

Agenda Item Image
Mr Jerry Henley
CEO
Azunic AI

Panellist

Agenda Item Image
Dr. Simona John von Freyend
Managing Director/CEO
PTNG Scientific

Panellist

Agenda Item Image
Dr. Jane Leong
Director and Chief Operating Officer
Australian Centre for AI in Medical Innovation

Chair

Agenda Item Image
Dr. Craig Rayner
CEO and Founder
Oktopi

Panellist

Agenda Item Image
Mr Sean Smith
Regional Director, APAC
Benchling

Panellist

loading